LANCE BRYSON: Open Payments
NPI 1306388350 · MORGANTOWN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 84 payments from 17 companies in 2025. Trend: 2023 $1,197 · 2024 $950 · 2025 $1,277
Food & beverage: $1,277
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 41 | $320 |
| PFIZER INC. | 9 | $189 |
| Dendreon Pharmaceuticals LLC | 7 | $180 |
| Janssen Biotech, Inc. | 5 | $109 |
| UROGEN PHARMA, INC. | 3 | $76 |
| Ferring Pharmaceuticals Inc. | 4 | $64 |
| ABBVIE INC. | 2 | $55 |
| TOLMAR, INC. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Procept Biorobotics Corporation | 1 | $33 |
Products named: XTANDI, PROVENGE, ORGOVYX, GEMTESA, ERLEADA, JELMYTO, ADSTILADRIN, BOTOX.
Industry payments across WV — which companies pay providers there.
